TABLE 1.
Characteristics of the stage 1 and 2 case and control samples
| Stage 1
|
Stage 2
|
|||
|---|---|---|---|---|
| Case subjects | Control subjects | Case subjects | Control subjects | |
| n | 1,161 | 1,174 | 1,215 | 1,258 |
| Male subjects | 653 | 574 | 724 | 768 |
| Female subjects | 508 | 600 | 491 | 490 |
| Age of diagnosis (years) | 53.0 ± 12.0 | N/A | 56.0 ± 12.0 | N/A |
| Study age (years) | 63.4 ± 11.2 | 64 ± 11.7 | 60.0 ± 11.5 | 59.0 ± 10.6 |
| BMI (kg/m2) | 29.8 ± 6.1 | 26.8 ± 5.0 | 30.1 ± 6.7 | 26.4 ± 4.9 |
| Fasting glucose (mmol/l) | 8.4 ± 3.9 | 5.4 ± 0.7 | 7.2 ± 2.1* | 5.4 ± 0.6† |
Data are medians±interquartile ranges unless otherwise indicated.
*
n = 204 and
†
n = 583 values converted from whole blood to plasma glucose equivalent using a prediction equation from the European Diabetes Epidemiology Group, of which †n = 262 fasted <8 h.